| characteristics |
Total
n=194 |
HIV
n=129 |
HIV/HCV
n=65 |
P < |
| Age years ± SD |
48.3 ± 8.5 |
48.5 ± 9.4 |
47.7 ± 5.9 |
ns |
| Male/Female |
121/73 |
74/55 |
47/18 |
ns |
| BMI (Kg/m2)± SD |
23.5 ± 3.1 |
23.8 ± 3.4 |
22.8 ±2.7 |
ns |
| Fracture (n, %) |
15 (7.7) |
7 (5.4) |
8 (12.3) |
ns |
| Ethnicity (n, %):
Caucasian |
181 (93.3) |
119 (92.2) |
62 (95.3) |
ns |
| African |
13 (6.7) |
10 (7.7) |
3 (4.6) |
ns |
| Smoking status (n, %):Non-smokers |
62 (32.0) |
50 (38.7) |
12 (18.4) |
0.03 |
| Smokers |
97 (50.0) |
57 (44.2) |
40 (61.5) |
| Former smokers |
35 (28 %) |
22 (17) |
13 (20) |
| Alcohol (n, %) |
20 (10.3) |
6 (4.6) |
14 (21.5) |
0.001 |
| Drug addiction (n, %) |
56 (28.8) |
14 (10.8) |
42 (64.6) |
0.0001 |
| IFG/Diabetes (n, %) |
45 (23.2) |
28 (21.7) |
17 (26.1) |
ns |
| Time since HIV diagnosis (years) (range) |
15 (0.1-29) |
12 (0.1-28) |
18 (0.1-29) |
0.0001 |
| Treatment-naïve (n, %) |
9 (4.7) |
7 (5.4) |
2 (3.0) |
ns |
| Previous antiretroviral therapy (years) (range) |
9 (0.5-26) |
8 (0.5-23) |
13 (0.5-26) |
0.0001 |
| Genotype 1/others (n, %) |
- |
- |
40 (61) |
- |
HIV: Human Immunodeficiency Virus; HCV: Hepatitis C Virus; SD: Standard Deviation; BMI: Body Mass Index; IFG: Impaired Fasting Glucose; FRS: Framingham Risk
Score; ns: Not Significant. |
